Ending the tuberculosis syndemic: is COVID-19 the (in)convenient scapegoat for poor progress?

doi:10.1016/S2213-2600(22)00123-0

Comment

. 2022 Jun;10(6):529-531.

doi: 10.1016/S2213-2600(22)00123-0. Epub 2022 Mar 23.

Ending the tuberculosis syndemic: is COVID-19 the (in)convenient scapegoat for poor progress?

Molebogeng X Rangaka¹, Yohhei Hamada², Ibrahim Abubakar³

Affiliations

¹ Institute for Global Health, University College London, London WC1N 1EH, UK; MRC Clinical Trials Unit, University College London, London, UK; Clinical Infectious Diseases Research Initiative (CIDRI)-AFRICA and School of Public Health, University of Cape Town, Cape Town, South Africa. Electronic address: l.rangaka@ucl.ac.uk.
² Institute for Global Health, University College London, London WC1N 1EH, UK.
³ Faculty of Population Health Sciences, University College London, London, UK.

PMID: 35338839
PMCID: PMC8942476
DOI: 10.1016/S2213-2600(22)00123-0

Comment

Ending the tuberculosis syndemic: is COVID-19 the (in)convenient scapegoat for poor progress?

Molebogeng X Rangaka et al. Lancet Respir Med. 2022 Jun.

. 2022 Jun;10(6):529-531.

doi: 10.1016/S2213-2600(22)00123-0. Epub 2022 Mar 23.

Authors

Molebogeng X Rangaka¹, Yohhei Hamada², Ibrahim Abubakar³

Affiliations

¹ Institute for Global Health, University College London, London WC1N 1EH, UK; MRC Clinical Trials Unit, University College London, London, UK; Clinical Infectious Diseases Research Initiative (CIDRI)-AFRICA and School of Public Health, University of Cape Town, Cape Town, South Africa. Electronic address: l.rangaka@ucl.ac.uk.
² Institute for Global Health, University College London, London WC1N 1EH, UK.
³ Faculty of Population Health Sciences, University College London, London, UK.

PMID: 35338839
PMCID: PMC8942476
DOI: 10.1016/S2213-2600(22)00123-0

No abstract available

PubMed Disclaimer

Conflict of interest statement

MXR is the recipient of a Wellcome Trust Investigator Award on tuberculosis and diabetes. IA is the recipient of an EU funded award to End-VOC (End SARS-CoV-2 variants of concern). The authors declare no other competing interests.

Figures

See this image and copyright information in PMC

Comment on

The intersecting pandemics of tuberculosis and COVID-19: population-level and patient-level impact, clinical presentation, and corrective interventions.
Dheda K, Perumal T, Moultrie H, Perumal R, Esmail A, Scott AJ, Udwadia Z, Chang KC, Peter J, Pooran A, von Delft A, von Delft D, Martinson N, Loveday M, Charalambous S, Kachingwe E, Jassat W, Cohen C, Tempia S, Fennelly K, Pai M. Dheda K, et al. Lancet Respir Med. 2022 Jun;10(6):603-622. doi: 10.1016/S2213-2600(22)00092-3. Epub 2022 Mar 23. Lancet Respir Med. 2022. PMID: 35338841 Free PMC article. Review.

Cited by

Severe outcomes among adults with TB during COVID-19.
Jacobs T, Morden E, Smith M, von Delft A, Kassanjee R, Mudaly V, Boulle A, Davies MA. Jacobs T, et al. IJTLD Open. 2024 Jul 1;1(7):292-298. doi: 10.5588/ijtldopen.24.0220. eCollection 2024 Jul. IJTLD Open. 2024. PMID: 39035425 Free PMC article.
Impact of COVID-19 Pandemic on Tuberculosis Preventive Services and Their Post-Pandemic Recovery Strategies: A Rapid Review of Literature.
Jeong Y, Min J. Jeong Y, et al. J Korean Med Sci. 2023 Feb 6;38(5):e43. doi: 10.3346/jkms.2023.38.e43. J Korean Med Sci. 2023. PMID: 36747365 Free PMC article. Review.

References

1. Singer M. Syndemics and the biosocial conception of health. Lancet. 2017;389:941–950. - PubMed
1. WHO . World Health Organization; Geneva: 2021. Global tuberculosis report 2021.
1. Dheda K, Perumal T, Moultrie H, et al. The intersecting pandemics of tuberculosis and COVID-19: population-level and patient-level impact, presentation, and corrective interventions. Lancet Respir Med. 2022 doi: 10.1016/S2213-2600(22)00092-3. published online March 23. - DOI - PMC - PubMed
1. Nathavitharana RR, Garcia-Basteiro AL, Ruhwald M, Cobelens F, Theron G. Reimagining the status quo: how close are we to rapid sputum-free tuberculosis diagnostics for all? EBioMedicine. 2022 doi: 10.1016/j.ebiom.2022.103939. published online March 23. - DOI - PMC - PubMed
1. Esmail H, Macpherson L, Coussens AK, Houben RMGJ. Mind the gap – managing tuberculosis across the disease spectrum. EBioMedicine. 2022 doi: 10.1016/j.ebiom.2022.103928. published online March 23. - DOI - PMC - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
Medical
- MedlinePlus Health Information

[1] Singer M. Syndemics and the biosocial conception of health. Lancet. 2017;389:941–950. - PubMed

[2] Singer M. Syndemics and the biosocial conception of health. Lancet. 2017;389:941–950. - PubMed

[3] WHO . World Health Organization; Geneva: 2021. Global tuberculosis report 2021.

[4] WHO . World Health Organization; Geneva: 2021. Global tuberculosis report 2021.

[5] Dheda K, Perumal T, Moultrie H, et al. The intersecting pandemics of tuberculosis and COVID-19: population-level and patient-level impact, presentation, and corrective interventions. Lancet Respir Med. 2022 doi: 10.1016/S2213-2600(22)00092-3. published online March 23. - DOI - PMC - PubMed

[6] Dheda K, Perumal T, Moultrie H, et al. The intersecting pandemics of tuberculosis and COVID-19: population-level and patient-level impact, presentation, and corrective interventions. Lancet Respir Med. 2022 doi: 10.1016/S2213-2600(22)00092-3. published online March 23. - DOI - PMC - PubMed

[7] Nathavitharana RR, Garcia-Basteiro AL, Ruhwald M, Cobelens F, Theron G. Reimagining the status quo: how close are we to rapid sputum-free tuberculosis diagnostics for all? EBioMedicine. 2022 doi: 10.1016/j.ebiom.2022.103939. published online March 23. - DOI - PMC - PubMed

[8] Nathavitharana RR, Garcia-Basteiro AL, Ruhwald M, Cobelens F, Theron G. Reimagining the status quo: how close are we to rapid sputum-free tuberculosis diagnostics for all? EBioMedicine. 2022 doi: 10.1016/j.ebiom.2022.103939. published online March 23. - DOI - PMC - PubMed

[9] Esmail H, Macpherson L, Coussens AK, Houben RMGJ. Mind the gap – managing tuberculosis across the disease spectrum. EBioMedicine. 2022 doi: 10.1016/j.ebiom.2022.103928. published online March 23. - DOI - PMC - PubMed

[10] Esmail H, Macpherson L, Coussens AK, Houben RMGJ. Mind the gap – managing tuberculosis across the disease spectrum. EBioMedicine. 2022 doi: 10.1016/j.ebiom.2022.103928. published online March 23. - DOI - PMC - PubMed

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Ending the tuberculosis syndemic: is COVID-19 the (in)convenient scapegoat for poor progress?

Affiliations

Ending the tuberculosis syndemic: is COVID-19 the (in)convenient scapegoat for poor progress?

Authors

Affiliations

Conflict of interest statement

Figures

Comment on

Similar articles

Cited by

References

Publication types

MeSH terms

LinkOut - more resources

Full Text Sources

Medical